WAVE Life Sciences Ltd.
WVE
$8.75
$0.121.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 208.48M | 243.08M | 302.08M | 310.95M | 153.96M |
| Total Receivables | 1.62M | -- | 1.42M | -- | 1.29M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.70M | 8.06M | 9.54M | 10.57M | 12.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.76M | 6.84M | 7.35M | 3.00M | 4.68M |
| Total Current Assets | 223.56M | 257.98M | 320.39M | 324.52M | 172.08M |
|
|
|||||
| Total Current Assets | 223.56M | 257.98M | 320.39M | 324.52M | 172.08M |
| Net Property, Plant & Equipment | 24.29M | 26.15M | 28.00M | 30.05M | 32.11M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.51M | 4.22M | 3.82M | 3.94M | 4.63M |
| Total Assets | 252.36M | 288.34M | 352.21M | 358.50M | 208.82M |
|
|
|||||
| Total Accounts Payable | 14.66M | 14.36M | 16.26M | 12.78M | 18.15M |
| Total Accrued Expenses | 13.03M | 7.81M | 21.08M | 14.64M | 10.68M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.14M | 7.88M | 7.64M | 7.40M | 7.16M |
| Total Finance Division Other Current Liabilities | 51.58M | 57.31M | 65.97M | 135.91M | 137.14M |
| Total Other Current Liabilities | 51.58M | 57.31M | 65.97M | 135.91M | 137.14M |
| Total Current Liabilities | 87.41M | 87.37M | 110.95M | 170.73M | 173.13M |
|
|
|||||
| Total Current Liabilities | 87.41M | 87.37M | 110.95M | 170.73M | 173.13M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 13.58M | 15.72M | 17.77M | 19.77M | 21.71M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.23M | 5.58M | 6.10M | 18.49M | 9.58M |
| Total Liabilities | 105.22M | 108.67M | 134.82M | 208.99M | 204.42M |
|
|
|||||
| Common Stock & APIC | 1.36B | 1.34B | 1.33B | 1.29B | 1.09B |
| Retained Earnings | -1.22B | -1.17B | -1.12B | -1.15B | -1.09B |
| Treasury Stock & Other | -161.00K | -204.00K | -262.00K | -159.00K | -279.00K |
| Total Common Equity | 139.27M | 171.80M | 209.52M | 141.64M | -3.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M |
|
|
|||||
| Total Common Equity | 139.27M | 171.80M | 209.52M | 141.64M | -3.48M |
| Total Preferred Equity | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 147.14M | 179.68M | 217.39M | 149.51M | 4.40M |
|
|
|||||